About Protein APCDD1
Protein APCDD1 (APCDD1) is a protein
from Homo sapiens identified by UniProt accession
Q8J025, 514 residues long.
MolForge cross-references it against 0 known binders and
99 disease associations.
Target properties
| Protein name | Protein APCDD1 |
| UniProt accession | Q8J025 |
| Gene | APCDD1 |
| Organism | Homo sapiens |
| Length | 514 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (99)
Diseases linked to this target (Open Targets).
- hypotrichosis simplex · score 0.59
- heel bone mineral density · score 0.43
- age at menopause · score 0.42
- cortical surface area measurement · score 0.41
- hair shape measurement · score 0.39
- balding measurement · score 0.37
- neurodegenerative disease · score 0.34
- alopecia · score 0.32
- venous thromboembolism · score 0.29
- bone quantitative ultrasound measurement · score 0.26
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q8J025-F1 | alphafold | PREDICTED | 81.79 | — |
Amino-acid sequence (514 residues)
MSWPRRLLLR YLFPALLLHG LGEGSALLHP DSRSHPRSLE KSAWRAFKES QCHHMLKHLH NGARITVQMP PTIEGHWVST GCEVRSGPEF ITRSYRFYHN NTFKAYQFYY GSNRCTNPTY TLIIRGKIRL RQASWIIRGG TEADYQLHNV QVICHTEAVA EKLGQQVNRT CPGFLADGGP WVQDVAYDLW REENGCECTK AVNFAMHELQ LIRVEKQYLH HNLDHLVEEL FLGDIHTDAT QRMFYRPSSY QPPLQNAKNH DHACIACRII YRSDEHHPPI LPPKADLTIG LHGEWVSQRC EVRPEVLFLT RHFIFHDNNN TWEGHYYHYS DPVCKHPTFS IYARGRYSRG VLSSRVMGGT EFVFKVNHMK VTPMDAATAS LLNVFNGNEC GAEGSWQVGI QQDVTHTNGC VALGIKLPHT EYEIFKMEQD ARGRYLLFNG QRPSDGSSPD RPEKRATSYQ MPLVQCASSS PRAEDLAEDS GSSLYGRAPG RHTWSLLLAA LACLVPLLHW NIRR
Explore Protein APCDD1 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets